Clinical Trials in New Haven, United States
Locations / New Haven, United States
Delta Trials records 5,550 clinical trials conducted in New Haven, United States, making it a notable site of clinical research activity. These trials across 5,257 distinct therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 636 trials in this location were terminated, reflecting shifts in research priorities or feasibility. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity in New Haven has changed over time.
5550
Total Trials
5257
Conditions
636
Terminated since 2020
Browse by condition (5257 total)
- Healthy 147 trialsAll Healthy trials
- Breast cancer 114 trialsAll Breast cancer trials
- HIV infections 101 trialsAll HIV infections trials
- Non-small cell lung cancer 91 trialsAll Non-small cell lung cancer trials
- Alzheimer's disease 85 trialsAll Alzheimer's disease trials
- Schizophrenia 70 trialsAll Schizophrenia trials
- Obesity 65 trialsAll Obesity trials
- Heart failure 62 trialsAll Heart failure trials
- Alzheimer's disease 61 trialsAll Alzheimer's disease trials
- Prostate cancer 60 trialsAll Prostate cancer trials
- Colorectal cancer 60 trialsAll Colorectal cancer trials
- Ovarian cancer 57 trialsAll Ovarian cancer trials
- Melanoma 54 trialsAll Melanoma trials
- Healthy volunteers 47 trialsAll Healthy volunteers trials
- Parkinson's disease 46 trialsAll Parkinson's disease trials
- Acute myeloid leukemia 46 trialsAll Acute myeloid leukemia trials
- Asthma 45 trialsAll Asthma trials
- Solid tumor 43 trialsAll Solid tumor trials
- Type 1 diabetes 43 trialsAll Type 1 diabetes trials
- Advanced solid tumors 41 trialsAll Advanced solid tumors trials